Jakarta, July 15th, 2022PT Kalbe Farma Tbk (Kalbe), through its subsidiary PT Sanghiang Perkasa (Kalbe Nutritionals) and YARSI University, has agreed to conduct a collaboration of nutrient intervention for pregnant women in order to quickly decrease stunting cases. This program will be conducted in Kresek, Tangerang Region, Banten, from July until Desember of 2022.

“Kalbe and its subsidiary Kalbe Nutritionals have provided the best nutritional solutions in all stages of human life, including for pregnant women and children. This collaboration will continue to support the best nutrients in an effort of decreasing stunting cases in order to create a healthy nation together,” as stated by the Director of Quality, Sustainability, and Support of Kalbe Nutritionals, Andy Chendra.

He then added, “Aside from providing extra nutrients such us milk for pregnant women, our activities also include an education about decreasing the stunting cases.”

Andy later stated that the collaboration with YARSI University and the Regional Government of Kresek would become a good synergy between the government, the academics, and the business parties, in order to assist the government in decreasing the stunting cases.

“We would like to support and express our gratitude for this collaboration with Kalbe Nutritionals, as a part of the synergy of multiparty roles between the government, the academics, the business world, and the industry world, in order to succesfully achieve the Sustainable Development Objective in Indonesia,” according to the Rector of YARSI University, Prof. dr. Fasli Jalal, Ph.D.

Fasli then stated that the Tangerang Region was chosen by the Government, because Banten is one of the twelve national priority provinces in the quick decrease of stunting national program. The location is also a partner of YARSI University in conducting the three pillars (Tridharma) of college, in particular the education for medical students of the YARSI Faculty of Medicine.

The Head of the YARSI University Stunting Team, dr. Yusnita, M.Kes., Sp.KKLP., stated that both Kalbe and YARSI wanted to assist the government in increasing the nutrient quality for individuals, families, and the society. In this case, stunting could be prevented and to prevent its disorders as well, by consuming the right nutrients.

Stunting is a chronic malnutrition disorder which causes a short body posture. A person contracted with it is generally vunarable to various diseases, as well as having a below average intellegence and lower productivity. Pregnant women become one main priority target in decreasing the stunting cases through family approach, by intervening all family members with such risk, including teenage girls, newlyweds, pregnant women, breastfeeding women, and toddlers.

Therefore, providing milk to pregnant women is necessary for increasing their weight, fulfilling their animal protein capacity, and decreasing their chances of anemia. All these things will prevent stunting to their babies or ensuring that they will reach a minimum lenght of 48 cm during their birth.

There are several indicators of success of this stunting program for pregnant women, such as drinking milk in routine, increasing the knowledge on stunting, providing a balanced diet menu, a clean and healthy behavior (PBHS), and evaluating the comparison of their nutrient indicators before and after the program.

YARSI University has previously conducted this program since 2019 in several regions, including in Pandeglang, Central Jakarta, and Bantar Sari Village in Bogor.

On the other hand, Kalbe Farma’s Sustainable Strategy of “Together We Heal the Nation” has shown its commitment in initiating the sustainability and fulfilling the needs of stakeholders. Kalbe also expresses its support in fulfilling the seventeen achievements of the the Sustainable Development Objective through the SEHAT Pillar, which includes Health Science and Technology, Environmental Ecosystems and Preservations, Healthy Living and Heelth Education, Access to Health Services, and the Total of Sustainable Business Ecosystems.


Kalbe at a Glance

Founded in 1966, PT Kalbe Farma Tbk (Kalbe) is one of the largest open pharmaceutical companies in Southeast Asia. The company has four main divisions that engage in a portfolio of reliable and diversed brands, such as the prescription medicine division, the health product division which handles free medicines, multivitamins, and ready-to-drink supplement beverages, and the distribution and logistics divisions.

Kalbe has also developed a digital service ecosystem for the society, both in B2B with EMOS and in B2C with KlikDokter. EMOS is an order management application system that facilitates the distribution channels in commencing stock management or supply chain, while KlikDokter is a digital platform for health services, specifically telemedicine, which provides necessary health consultations and products for the society.

Now, Kalbe has more than 40 subsidiaries and 15 production facilities with international standards, employing around 16.000 employees who are being stationed in 76 branches all around Indonesia. Kalbe’s shares has been recorded in the Indonesia Stock Exchange (IDX) since 1991 (IDX:KLBF).

623 Rate this article:

Please login or register to post comments.